In the world of love and dating, prejudice against the trans community remains prevalent. A 2018 study asked 958 participants ...

In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...

Unilever said its ice cream business will be separated by way of demerger, through listing of the business in Amsterdam, ...

The search for the best swimsuit brands can leave you drowning in a sea of options, whatever time of year it is. But for 2025, the quest for beach and poolside excellence will be easier, because the ...

While jumpers come into play during autumn and winter, they’re truly a year-round staple, which means that having a mental rolodex of the best knitwear brands is essential. Certain labels have ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

OpenAI has finally unveiled its first major rebrand, with a similar but new logo, a new typeface, and colour palette. This change aims to create a more organic and more human brand identity, according ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside better-than-expected earnings for Q4 ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential functional cure for the infectious disease. On a media call Wednesday morning ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares opened today ...

GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical giant said Wednesday that the 2.0 billion ...